The significant growth in the ambulatory surgical centers
market can be credited to several factors highlighting the rising
need for multispecialty outpatient surgical facilities. A primary
driver behind this upward trend is the growing favoritism towards
outpatient surgical centers over traditional hospitals. The
inherent benefit of reduced costs associated with outpatient
centers compared to hospitals has become a crucial factor impacting
patient decisions. This affordability, along with favorable
reimbursement conditions, is anticipated to greatly impact the
expanding ambulatory surgical centers market.
LAS VEGAS, May 23, 2024 /PRNewswire/ -- DelveInsight's
Ambulatory Surgical Centers Market Insights report
provides the current and forecast market analysis, individual
leading ambulatory surgical centers companies' market shares,
challenges, ambulatory surgical centers market drivers, barriers,
trends, and key market ambulatory surgical centers companies in the
market.
Key Takeaways from the Ambulatory Surgical Centers Market
Report
- As per DelveInsight estimates, North
America is anticipated to dominate the global ambulatory
surgical centers market during the forecast period.
- Notable ambulatory surgical centers companies such as
AMSURG, Surgical Care Affiliates, HCA Healthcare, Tenet
Healthcare, Surgery Partners, Cerner Corporation, United Surgical
Partners International, Hunterdon Healthcare, Surg Center Gilbert,
Beaumont Health, Ambulatory Surgical Centers of America, Center for
Health Ambulatory Surgery Centers, TeamHealth, Pediatrix Medical
Group, Quoram Health Corporation, and several others, are
currently operating in the ambulatory surgical centers market.
- In January 2021, T.H.
Medical announced the plans to acquire up to about 25 to 40
ambulatory surgical centers. The company plans to spend an
estimated USD 150 million on the
acquisition of these surgery centers.
- In January 2018, Medical
Facilities Corporation announced an agreement with NueHealth
LLC to form a joint venture and acquire seven ambulatory surgical
centers from Meridian Surgical Partners of Brentwood.
To read more about the latest highlights related to the
ambulatory surgical centers market, get a snapshot of the key
highlights entailed in the Global Ambulatory Surgical Centers
Market Report
Ambulatory Surgical Centers Overview
Ambulatory Surgical Centers (ASCs) represent a pivotal evolution
in healthcare delivery, providing specialized surgical procedures
in an outpatient setting. These centers are designed to offer
patients a more convenient, cost-effective, and efficient
alternative to traditional hospital-based surgeries. Equipped with
state-of-the-art technology and staffed by skilled medical
professionals, ASCs cater to a wide range of surgical needs,
spanning from minor procedures to more complex interventions. Their
streamlined operations often translate to shorter wait times,
reduced overheads, and a focused approach to patient care,
fostering a personalized experience that prioritizes both comfort
and safety.
With their emphasis on same-day procedures and swift recovery,
Ambulatory Surgical Centers have significantly transformed the
landscape of healthcare. Their ability to perform surgeries outside
of the hospital environment not only alleviates strain on inpatient
facilities but also minimizes the risks associated with prolonged
hospital stays, such as infections and patient discomfort.
Furthermore, ASCs play a crucial role in enhancing accessibility to
surgical care, particularly for individuals requiring elective
surgeries or routine procedures. By combining efficiency with
excellence in medical care, Ambulatory Surgical Centers continue to
emerge as indispensable pillars of modern healthcare delivery,
shaping a paradigm where convenience and quality converge for the
benefit of patients and healthcare providers alike.
Ambulatory Surgical Centers Market Insights
In the realm of global ambulatory surgical centers, North America maintained its leading position
in 2023 and is forecasted to do so from 2024 to 2030. Several
factors contribute to this expected dominance, including the
increasing preference for ambulatory surgical centers among
physicians and patients in the region.
The growing demand for these centers is fueled by factors like a
rising number of patients with chronic diseases such as
cardiovascular and urological conditions. Additionally, the
increasing elderly population in North
America, who are more prone to cardiovascular, neurological,
and urological disorders, is another significant factor driving the
need for ambulatory surgical centers. As per the U.S. Census Bureau
in 2021, there were over 54 million adults aged 65 and older in
the United States, with
projections indicating a rise to 85.7 million by 2050.
Furthermore, the region benefits from a growing awareness of
minimally invasive surgical procedures and favorable reimbursement
policies for ambulatory surgical centers. The rising demand for
advanced imaging systems within these centers also contributes to
market growth. Notably, governmental initiatives, along with
significant investments from various organizations and key industry
players, aimed at improving healthcare infrastructure in
North America, are expected to
significantly boost the market growth of ambulatory surgical
centers.
Therefore, the combination of these factors creates a favorable
growth environment for North
America in the ambulatory surgical centers market. The
region stands as a pivotal player in advancing healthcare
solutions, driven by the collaborative efforts of stakeholders to
address the evolving needs of the population and enhance overall
health outcomes.
To know more about why North
America is leading the market growth in the ambulatory
surgical centers market, get a snapshot of the Ambulatory
Surgical Centers Market Outlook
Ambulatory Surgical Centers Market Dynamics
The ambulatory surgical centers market has witnessed significant
growth in recent years, driven by several key dynamics. One
prominent factor is the increasing demand for cost-effective
healthcare solutions, coupled with advancements in medical
technology. Ambulatory surgical centers offer a convenient and
efficient alternative to traditional hospital-based surgery,
providing patients with high-quality care in a more comfortable
setting. This shift towards outpatient procedures has been further
accelerated by changes in reimbursement policies, which
incentivize healthcare providers to perform surgeries in ambulatory
surgical centers rather than hospitals.
Moreover, the rising prevalence of chronic diseases and
the aging population have contributed to the expansion of
the ambulatory surgical centers market. As the demand for surgical
procedures continues to grow, ambulatory surgical centers play a
vital role in meeting this demand by offering specialized
services and shorter wait times. Additionally, ambulatory
surgical centers such as minimally invasive techniques have enabled
a wider range of procedures to be performed in ambulatory surgical
centers, further driving ambulatory surgical centers' market
growth.
However, the ambulatory surgical centers market also faces
challenges such as regulatory compliance, reimbursement issues,
and competition from other healthcare providers. Regulatory
requirements vary across regions, and ambulatory surgical centers
must adhere to strict standards to ensure patient safety and
quality of care. Furthermore, reimbursement policies can
impact the financial viability of ambulatory surgical centers, and
changes in reimbursement rates or regulations can have
significant implications for their operations. Despite these
challenges, the ambulatory surgical centers market is expected to
continue expanding as healthcare delivery models evolve, and
ambulatory surgical centers play an increasingly important role in
delivering efficient and accessible surgical care.
Get a sneak peek at the ambulatory surgical centers market
dynamics @ Ambulatory Surgical Centers Market Dynamics
Analysis
Report
Metrics
|
Details
|
Coverage
|
Global
|
Study Period
|
2021–2030
|
Ambulatory Surgical
Centers Market CAGR
|
~6%
|
Ambulatory Surgical
Centers Market Size by 2030
|
USD 820.57
Million
|
Key Ambulatory Surgical
Centers Companies
|
AMSURG, Surgical Care
Affiliates, HCA Healthcare, Tenet Healthcare, Surgery Partners,
Cerner Corporation, United Surgical Partners International,
Hunterdon Healthcare, Surg Center Gilbert, Beaumont Health,
Ambulatory Surgical Centers of America, Center for Health
Ambulatory Surgery Centers, TeamHealth, Pediatrix Medical Group,
Quoram Health Corporation, among others
|
Ambulatory Surgical Centers Market Assessment
- Ambulatory Surgical Centers Market Segmentation
-
- Ambulatory Surgical Centers Market Segmentation By Type:
Hospital-Affiliated Ambulatory Surgical Centers (Single-Specialty
Centers And Multi-Specialty Centers), and Freestanding Ambulatory
Surgical Centers (Single-Specialty Centers and Multi-Specialty
Centers)
- Ambulatory Surgical Centers Market Segmentation By
Application: Gastroenterology, Ophthalmology, Orthopedics,
Pain/Neurology, Urology, Dermatology
- Ambulatory Surgical Centers Market Segmentation By
Geography: North America,
Europe, Asia-Pacific, and Rest of World
- Porter's Five Forces Analysis, Product Profiles, Case
Studies, KOL's Views, Analyst's View
Which MedTech key players in the ambulatory surgical centers
market are set to emerge as the trendsetter explore @ Ambulatory
Surgical Centers Companies
Table of Contents
1
|
Report
Introduction
|
2
|
Executive
summary
|
3
|
Regulatory and Patent
Analysis
|
4
|
Key Factors
Analysis
|
5
|
Porter's Five Forces
Analysis
|
6
|
Ambulatory Surgical
Centers Market Layout
|
7
|
Global Company Share
Analysis – Key 3-5 Companies
|
8
|
Ambulatory Surgical
Centers Market Company and Product
Profiles
|
9
|
Project
Approach
|
10
|
About
DelveInsight
|
Interested in knowing the ambulatory surgical centers market by
2030? Click to get a snapshot of the Ambulatory Surgical
Centers Market Trends
Related Reports
Irritable Bowel Syndrome Market
Irritable Bowel Syndrome Market Insights, Epidemiology, and
Market Forecast – 2032 report deliver an in-depth
understanding of the disease, historical and forecasted
epidemiology, as well as the market trends, market drivers, market
barriers, and key irritable bowel syndrome companies, including
Arena Pharmaceuticals, 4D Pharma, NGM Biopharmaceuticals,
OrphoMed, Boston Pharmaceuticals, RedHill Biopharma Limited,
Takeda, Cosmo Technologies, CinRx Pharma, Rottapharm, Synthetic
Biologics, Biomica, Metacrine, MGC Pharma, Napo Pharmaceuticals,
Novome Biotechnologies, Renexxion, Sentia Medical Sciences,
Serentrix LLC, Vitality Biopharma, among others.
Ulcerative Colitis Market
Ulcerative Colitis Market Insights, Epidemiology, and Market
Forecast – 2032 report delivers an in-depth understanding
of the market trends, market drivers, market barriers, and key
Ulcerative Colitis companies, including Eli Lilly and Company,
Lipid Therapeutics, Hoffmann-La Roche, Arena Pharmaceuticals, InDex
Pharmaceuticals, EA Pharma, Theravance Biopharma, Boehringer
Ingelheim, Janssen Research & Development, Lycera, LG Chem,
Iltoo Pharma, Immunic, Hutchison Medipharma, Tianjin Hemay
Pharmaceutical, Celgene, among others.
Crohn's Disease Pipeline
Crohn's Disease Pipeline Insight –
2024 report provides comprehensive insights about the
pipeline landscape, pipeline drug profiles, including clinical and
non-clinical stage products, and the key Crohn's
disease companies, including Janssen, RedHill Biopharma,
Amgen, Pfizer, Prometheus Biosciences, AgomAb Therapeutics,
Hoffmann-La Roche, Gilead Sciences, Eli Lilly and Company, Celgene,
AstraZeneca, Mesoblast, Alfasigma, Tiziana Life Sciences, Abivax,
Arena Pharmaceuticals, Cytocom, HAV Vaccines Ltd, Enzo Biochem
Inc., Stero Biotechs, Reistone Biopharma Company Limited, Qu
Biologics, Pfizer, Mitsubishi Tanabe Pharma Corporation, Takeda
Pharmaceuticals, Soligenix, Immunic, Pfizer, Atlantic Healthcare,
4D Pharma, Landos Biopharma, Janssen, Roche, Eisai, Bristol-Myers
Squibb, Iltoo Pharma, Suzhou Connect Biopharmaceuticals, Theravance
Biopharma, TaiwanJ Pharmaceuticals, Celularity, Cerecor,
GlaxoSmithKline, KangStem Biotech, Immunic, Alpha Cancer
Technologies, Koutif Therapeutics, Tract Therapeutics, Trio
medicines, ChemoCentryx, Algernon Pharmaceuticals, Neuclone, JHL
Biotech, Innovative Pharmacological Research (IPHAR) Co Ltd,
Innovation Pharmaceuticals, Exeliom Biosciences SAS, AbbVie, Finch
Therapeutics, Akeso Biopharma, Draconis Pharma, MakScientific,
Engitix, Origo Biopharma, Navidea Biopharmaceuticals, Orchard
Therapeutics, Xbrane, Thetis Pharmaceuticals, Temisis Therapeutics,
Synedgen, Synlogic, Morphic Therapeutic, Metacrine, Curacle,
Commence Bio Inc, Cloud Pharmaceuticals, Chong Kun Dang
Pharmaceutical Corp, Avobis Bio LLC, Avexegen Therapeutics,
Assembly Biosciences, Aibios Co Ltd, Aclaris Therapeutics, Athos
Therapeutics, Denali Therapeutics, Educell doo, among
others.
Irritable Bowel Syndrome Pipeline
Irritable Bowel Syndrome Pipeline Insight –
2024 report provides comprehensive insights about the
pipeline landscape, pipeline drug profiles, including clinical and
non-clinical stage products, and the key irritable bowel
syndrome companies, including Arena Pharmaceuticals, 4D
Pharma, OrphoMed, Boston Pharmaceuticals, RedHill Biopharma
Limited, Takeda, Cosmo Technologies, CinRx Pharma, Rottapharm,
Synthetic Biologics, Biomica, Metacrine, MGC Pharma, Napo
Pharmaceuticals, Novome Biotechnologies, Renexxion, Sentia Medical
Sciences, Serentrix LLC, Vitality Biopharma, among others.
About DelveInsight
DelveInsight is a leading Business Consultant, and Market
Research firm focused exclusively on life sciences. It supports
pharma companies by providing comprehensive end-to-end solutions to
improve their performance.
Contact Us
Shruti
Thakur
info@delveinsight.com
+14699457679
https://www.delveinsight.com/medical-devices
Logo:
https://mma.prnewswire.com/media/1082265/DelveInsight_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/global-ambulatory-surgical-centers-market-is-projected-to-boost-at-a-moderate-growth-rate-of-6-by-2030--delveinsight-302153730.html